APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biodegradable Coronary Stents

Compare research editions
View pricing & licenses

Selected research

Industry Research

Biodegradable Coronary Stents Industry Research Report 2026

26 December 2025138 pages

Choose your research edition.

Industry ResearchBiodegradable Coronary Stents Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Biodegradable Coronary Stents Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Biodegradable Coronary Stents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biodegradable Coronary Stents Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Biodegradable Coronary Stents Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Biodegradable Coronary Stents market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Biodegradable Coronary Stents is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Biodegradable Coronary Stents is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Biodegradable Coronary Stents is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Biodegradable Coronary Stents include Abbott, Terumo, Shandong Huaan Biotechnology, Boston Scientific, Wego Healthcare, SMT, SINOMED, REVA Medical (1) and Q3 Medical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Biodegradable Coronary Stents market in terms of revenue (US$ million) and, where applicable, sales volume (Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Biodegradable Coronary Stents Market by Company

Abbott

Terumo

Shandong Huaan Biotechnology

Boston Scientific

Wego Healthcare

SMT

SINOMED

REVA Medical (1)

Q3 Medical

Lepu Medical

Kyoto Medical

Elixir Medical

Cardionovum

Biotronik

Arterius

AMG International

Amaranth Medical

3M

Biodegradable Coronary Stents Segment by Type

Polylactic Acid (PLA)

Magnesium Alloys

Others

Biodegradable Coronary Stents Segment by Application

Percutaneous Coronary Intervention (PCI)

Post-Procedure Management

Drug-Eluting

Biodegradable Coronary Stents Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biodegradable Coronary Stents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biodegradable Coronary Stents and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biodegradable Coronary Stents.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Biodegradable Coronary Stents manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Biodegradable Coronary Stents by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Biodegradable Coronary Stents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Biodegradable Coronary Stents Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Biodegradable Coronary Stents Sales (Units) of Manufacturers (2021-2026) Table 7. Global Biodegradable Coronary Stents Sales Market Share by Manufacturers (2021-2026) Table 8. Global Biodegradable Coronary Stents Revenue of Manufacturers (2021-2026) Table 9. Global Biodegradable Coronary Stents Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Biodegradable Coronary Stents Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Biodegradable Coronary Stents Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Biodegradable Coronary Stents, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Biodegradable Coronary Stents, Product Type & Application Table 14. Global Biodegradable Coronary Stents Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Biodegradable Coronary Stents by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Abbott Company Information Table 19. Abbott Business Overview Table 20. Abbott Biodegradable Coronary Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Abbott Biodegradable Coronary Stents Product Portfolio Table 22. Abbott Recent Developments Table 23. Terumo Company Information Table 24. Terumo Business Overview Table 25. Terumo Biodegradable Coronary Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Terumo Biodegradable Coronary Stents Product Portfolio Table 27. Terumo Recent Developments Table 28. Shandong Huaan Biotechnology Company Information Table 29. Shandong Huaan Biotechnology Business Overview Table 30. Shandong Huaan Biotechnology Biodegradable Coronary Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Shandong Huaan Biotechnology Biodegradable Coronary Stents Product Portfolio Table 32. Shandong Huaan Biotechnology Recent Developments Table 33. Boston Scientific Company Information Table 34. Boston Scientific Business Overview Table 35. Boston Scientific Biodegradable Coronary Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Boston Scientific Biodegradable Coronary Stents Product Portfolio Table 37. Boston Scientific Recent Developments Table 38. Wego Healthcare Company Information Table 39. Wego Healthcare Business Overview Table 40. Wego Healthcare Biodegradable Coronary Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Wego Healthcare Biodegradable Coronary Stents Product Portfolio Table 42. Wego Healthcare Recent Developments Table 43. SMT Company Information Table 44. SMT Business Overview Table 45. SMT Biodegradable Coronary Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. SMT Biodegradable Coronary Stents Product Portfolio Table 47. SMT Recent Developments Table 48. SINOMED Company Information Table 49. SINOMED Business Overview Table 50. SINOMED Biodegradable Coronary Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. SINOMED Biodegradable Coronary Stents Product Portfolio Table 52. SINOMED Recent Developments Table 53. REVA Medical (1) Company Information Table 54. REVA Medical (1) Business Overview Table 55. REVA Medical (1) Biodegradable Coronary Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. REVA Medical (1) Biodegradable Coronary Stents Product Portfolio Table 57. REVA Medical (1) Recent Developments Table 58. Q3 Medical Company Information Table 59. Q3 Medical Business Overview Table 60. Q3 Medical Biodegradable Coronary Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Q3 Medical Biodegradable Coronary Stents Product Portfolio Table 62. Q3 Medical Recent Developments Table 63. Lepu Medical Company Information Table 64. Lepu Medical Business Overview Table 65. Lepu Medical Biodegradable Coronary Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Lepu Medical Biodegradable Coronary Stents Product Portfolio Table 67. Lepu Medical Recent Developments Table 68. Kyoto Medical Company Information Table 69. Kyoto Medical Business Overview Table 70. Kyoto Medical Biodegradable Coronary Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Kyoto Medical Biodegradable Coronary Stents Product Portfolio Table 72. Kyoto Medical Recent Developments Table 73. Elixir Medical Company Information Table 74. Elixir Medical Business Overview Table 75. Elixir Medical Biodegradable Coronary Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Elixir Medical Biodegradable Coronary Stents Product Portfolio Table 77. Elixir Medical Recent Developments Table 78. Cardionovum Company Information Table 79. Cardionovum Business Overview Table 80. Cardionovum Biodegradable Coronary Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Cardionovum Biodegradable Coronary Stents Product Portfolio Table 82. Cardionovum Recent Developments Table 83. Biotronik Company Information Table 84. Biotronik Business Overview Table 85. Biotronik Biodegradable Coronary Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Biotronik Biodegradable Coronary Stents Product Portfolio Table 87. Biotronik Recent Developments Table 88. Arterius Company Information Table 89. Arterius Business Overview Table 90. Arterius Biodegradable Coronary Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Arterius Biodegradable Coronary Stents Product Portfolio Table 92. Arterius Recent Developments Table 93. AMG International Company Information Table 94. AMG International Business Overview Table 95. AMG International Biodegradable Coronary Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. AMG International Biodegradable Coronary Stents Product Portfolio Table 97. AMG International Recent Developments Table 98. Amaranth Medical Company Information Table 99. Amaranth Medical Business Overview Table 100. Amaranth Medical Biodegradable Coronary Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Amaranth Medical Biodegradable Coronary Stents Product Portfolio Table 102. Amaranth Medical Recent Developments Table 103. 3M Company Information Table 104. 3M Business Overview Table 105. 3M Biodegradable Coronary Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. 3M Biodegradable Coronary Stents Product Portfolio Table 107. 3M Recent Developments Table 108. Global Biodegradable Coronary Stents Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 109. Global Biodegradable Coronary Stents Sales by Region (2021-2026) & (Units) Table 110. Global Biodegradable Coronary Stents Sales Market Share by Region (2021-2026) Table 111. Global Biodegradable Coronary Stents Sales by Region (2027-2032) & (Units) Table 112. Global Biodegradable Coronary Stents Sales Market Share by Region (2027-2032) Table 113. Global Biodegradable Coronary Stents Revenue by Region (2021-2026) & (US$ Million) Table 114. Global Biodegradable Coronary Stents Revenue Market Share by Region (2021-2026) Table 115. Global Biodegradable Coronary Stents Revenue by Region (2027-2032) & (US$ Million) Table 116. Global Biodegradable Coronary Stents Revenue Market Share by Region (2027-2032) Table 117. North America Biodegradable Coronary Stents Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. North America Biodegradable Coronary Stents Sales by Country (2021-2026) & (Units) Table 119. North America Biodegradable Coronary Stents Sales by Country (2027-2032) & (Units) Table 120. North America Biodegradable Coronary Stents Revenue by Country (2021-2026) & (US$ Million) Table 121. North America Biodegradable Coronary Stents Revenue by Country (2027-2032) & (US$ Million) Table 122. Europe Biodegradable Coronary Stents Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Europe Biodegradable Coronary Stents Sales by Country (2021-2026) & (Units) Table 124. Europe Biodegradable Coronary Stents Sales by Country (2027-2032) & (Units) Table 125. Europe Biodegradable Coronary Stents Revenue by Country (2021-2026) & (US$ Million) Table 126. Europe Biodegradable Coronary Stents Revenue by Country (2027-2032) & (US$ Million) Table 127. Asia Pacific Biodegradable Coronary Stents Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. Asia Pacific Biodegradable Coronary Stents Sales by Country (2021-2026) & (Units) Table 129. Asia Pacific Biodegradable Coronary Stents Sales by Country (2027-2032) & (Units) Table 130. Asia Pacific Biodegradable Coronary Stents Revenue by Country (2021-2026) & (US$ Million) Table 131. Asia Pacific Biodegradable Coronary Stents Revenue by Country (2027-2032) & (US$ Million) Table 132. South America Biodegradable Coronary Stents Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. South America Biodegradable Coronary Stents Sales by Country (2021-2026) & (Units) Table 134. South America Biodegradable Coronary Stents Sales by Country (2027-2032) & (Units) Table 135. South America Biodegradable Coronary Stents Revenue by Country (2021-2026) & (US$ Million) Table 136. South America Biodegradable Coronary Stents Revenue by Country (2027-2032) & (US$ Million) Table 137. Middle East and Africa Biodegradable Coronary Stents Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. Middle East and Africa Biodegradable Coronary Stents Sales by Country (2021-2026) & (Units) Table 139. Middle East and Africa Biodegradable Coronary Stents Sales by Country (2027-2032) & (Units) Table 140. Middle East and Africa Biodegradable Coronary Stents Revenue by Country (2021-2026) & (US$ Million) Table 141. Middle East and Africa Biodegradable Coronary Stents Revenue by Country (2027-2032) & (US$ Million) Table 142. Global Biodegradable Coronary Stents Sales by Type (2021-2026) & (Units) Table 143. Global Biodegradable Coronary Stents Sales by Type (2027-2032) & (Units) Table 144. Global Biodegradable Coronary Stents Sales Market Share by Type (2021-2026) Table 145. Global Biodegradable Coronary Stents Sales Market Share by Type (2027-2032) Table 146. Global Biodegradable Coronary Stents Revenue by Type (2021-2026) & (US$ Million) Table 147. Global Biodegradable Coronary Stents Revenue by Type (2027-2032) & (US$ Million) Table 148. Global Biodegradable Coronary Stents Revenue Market Share by Type (2021-2026) Table 149. Global Biodegradable Coronary Stents Revenue Market Share by Type (2027-2032) Table 150. Global Biodegradable Coronary Stents Price by Type (2021-2026) & (US$/Unit) Table 151. Global Biodegradable Coronary Stents Price by Type (2027-2032) & (US$/Unit) Table 152. Global Biodegradable Coronary Stents Sales by Application (2021-2026) & (Units) Table 153. Global Biodegradable Coronary Stents Sales by Application (2027-2032) & (Units) Table 154. Global Biodegradable Coronary Stents Sales Market Share by Application (2021-2026) Table 155. Global Biodegradable Coronary Stents Sales Market Share by Application (2027-2032) Table 156. Global Biodegradable Coronary Stents Revenue by Application (2021-2026) & (US$ Million) Table 157. Global Biodegradable Coronary Stents Revenue by Application (2027-2032) & (US$ Million) Table 158. Global Biodegradable Coronary Stents Revenue Market Share by Application (2021-2026) Table 159. Global Biodegradable Coronary Stents Revenue Market Share by Application (2027-2032) Table 160. Global Biodegradable Coronary Stents Price by Application (2021-2026) & (US$/Unit) Table 161. Global Biodegradable Coronary Stents Price by Application (2027-2032) & (US$/Unit) Table 162. Key Raw Materials Table 163. Raw Materials Key Suppliers Table 164. Biodegradable Coronary Stents Distributors List Table 165. Biodegradable Coronary Stents Customers List Table 166. Biodegradable Coronary Stents Industry Trends Table 167. Biodegradable Coronary Stents Industry Drivers Table 168. Biodegradable Coronary Stents Industry Restraints Table 169. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Biodegradable Coronary Stents Product Image Figure 5. Global Biodegradable Coronary Stents Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Biodegradable Coronary Stents Market Size (2021-2032) & (US$ Million) Figure 7. Global Biodegradable Coronary Stents Sales (2021-2032) & (Units) Figure 8. Global Biodegradable Coronary Stents Average Price (US$/Unit) & (2021-2032) Figure 9. Polylactic Acid (PLA) Product Image Figure 10. Magnesium Alloys Product Image Figure 11. Others Product Image Figure 12. Percutaneous Coronary Intervention (PCI) Product Image Figure 13. Post-Procedure Management Product Image Figure 14. Drug-Eluting Product Image Figure 15. Global Biodegradable Coronary Stents Revenue Share by Manufacturers in 2025 Figure 16. Global Manufacturers of Biodegradable Coronary Stents, Manufacturing Sites & Headquarters Figure 17. Global Top 5 and 10 Biodegradable Coronary Stents Players Market Share by Revenue in 2025 Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Biodegradable Coronary Stents Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 20. Global Biodegradable Coronary Stents Sales by Region in 2025 Figure 21. Global Biodegradable Coronary Stents Revenue by Region in 2025 Figure 22. North America Biodegradable Coronary Stents Market Size by Country in 2025 Figure 23. North America Biodegradable Coronary Stents Sales Market Share by Country (2021-2032) Figure 24. North America Biodegradable Coronary Stents Revenue Market Share by Country (2021-2032) Figure 25. United States Biodegradable Coronary Stents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Canada Biodegradable Coronary Stents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Mexico Biodegradable Coronary Stents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Europe Biodegradable Coronary Stents Market Size by Country in 2025 Figure 29. Europe Biodegradable Coronary Stents Sales Market Share by Country (2021-2032) Figure 30. Europe Biodegradable Coronary Stents Revenue Market Share by Country (2021-2032) Figure 31. Germany Biodegradable Coronary Stents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. France Biodegradable Coronary Stents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. U.K. Biodegradable Coronary Stents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Italy Biodegradable Coronary Stents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Russia Biodegradable Coronary Stents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Spain Biodegradable Coronary Stents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Netherlands Biodegradable Coronary Stents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Switzerland Biodegradable Coronary Stents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Sweden Biodegradable Coronary Stents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Poland Biodegradable Coronary Stents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Asia Pacific Biodegradable Coronary Stents Market Size by Country in 2025 Figure 42. Asia Pacific Biodegradable Coronary Stents Sales Market Share by Country (2021-2032) Figure 43. Asia Pacific Biodegradable Coronary Stents Revenue Market Share by Country (2021-2032) Figure 44. China Biodegradable Coronary Stents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Japan Biodegradable Coronary Stents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. South Korea Biodegradable Coronary Stents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. India Biodegradable Coronary Stents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Australia Biodegradable Coronary Stents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Taiwan Biodegradable Coronary Stents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Biodegradable Coronary Stents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Biodegradable Coronary Stents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. South America Biodegradable Coronary Stents Market Size by Country in 2025 Figure 53. South America Biodegradable Coronary Stents Sales Market Share by Country (2021-2032) Figure 54. South America Biodegradable Coronary Stents Revenue Market Share by Country (2021-2032) Figure 55. Brazil Biodegradable Coronary Stents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Argentina Biodegradable Coronary Stents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Chile Biodegradable Coronary Stents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Middle East and Africa Biodegradable Coronary Stents Market Size by Country in 2025 Figure 59. Middle East and Africa Biodegradable Coronary Stents Sales Market Share by Country (2021-2032) Figure 60. Middle East and Africa Biodegradable Coronary Stents Revenue Market Share by Country (2021-2032) Figure 61. Egypt Biodegradable Coronary Stents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. South Africa Biodegradable Coronary Stents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Israel Biodegradable Coronary Stents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Türkiye Biodegradable Coronary Stents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. GCC Countries Biodegradable Coronary Stents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Global Biodegradable Coronary Stents Sales Market Share by Type (2021-2032) Figure 67. Global Biodegradable Coronary Stents Revenue Market Share by Type (2021-2032) Figure 68. Global Biodegradable Coronary Stents Price (US$/Unit) by Type (2021-2032) Figure 69. Global Biodegradable Coronary Stents Sales Market Share by Application (2021-2032) Figure 70. Global Biodegradable Coronary Stents Revenue Market Share by Application (2021-2032) Figure 71. Global Biodegradable Coronary Stents Price (US$/Unit) by Application (2021-2032) Figure 72. Biodegradable Coronary Stents Value Chain Figure 73. Biodegradable Coronary Stents Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Biodegradable Coronary Stents Industry Opportunities and Challenges

Scope & coverage.

Types
  • Polylactic Acid (PLA)
  • Magnesium Alloys
  • Others
Applications
  • Percutaneous Coronary Intervention (PCI)
  • Post-Procedure Management
  • Drug-Eluting
Companies covered
  • Abbott
  • Terumo
  • Shandong Huaan Biotechnology
  • Boston Scientific
  • Wego Healthcare
  • SMT
  • SINOMED
  • REVA Medical (1)
  • Q3 Medical
  • Lepu Medical
  • Kyoto Medical
  • Elixir Medical
  • Cardionovum
  • Biotronik
  • Arterius
  • AMG International
  • Amaranth Medical
  • 3M

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Biodegradable Coronary Stents Market Size (2021-2032)
  4. 2.2.2 Global Biodegradable Coronary Stents Sales (2021-2032)
  5. 2.2.3 Global Biodegradable Coronary Stents Market Average Price (2021-2032)
  6. 2.3 Biodegradable Coronary Stents by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Polylactic Acid (PLA)
  9. 2.3.3 Magnesium Alloys
  10. 2.3.4 Others
  11. 2.4 Biodegradable Coronary Stents by Application
  12. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  13. 2.4.2 Percutaneous Coronary Intervention (PCI)
  14. 2.4.3 Post-Procedure Management
  15. 2.4.4 Drug-Eluting
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Biodegradable Coronary Stents Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Biodegradable Coronary Stents Sales (Units) of Manufacturers (2021-2026)
  3. 3.3 Global Biodegradable Coronary Stents Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Biodegradable Coronary Stents Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Biodegradable Coronary Stents Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Biodegradable Coronary Stents, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Biodegradable Coronary Stents, Product Type & Application
  8. 3.8 Global Manufacturers of Biodegradable Coronary Stents, Established Date
  9. 3.9 Global Biodegradable Coronary Stents Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Abbott
  2. 4.1.1 Abbott Company Information
  3. 4.1.2 Abbott Business Overview
  4. 4.1.3 Abbott Biodegradable Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Abbott Biodegradable Coronary Stents Product Portfolio
  6. 4.1.5 Abbott Recent Developments
  7. 4.2 Terumo
  8. 4.2.1 Terumo Company Information
  9. 4.2.2 Terumo Business Overview
  10. 4.2.3 Terumo Biodegradable Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Terumo Biodegradable Coronary Stents Product Portfolio
  12. 4.2.5 Terumo Recent Developments
  13. 4.3 Shandong Huaan Biotechnology
  14. 4.3.1 Shandong Huaan Biotechnology Company Information
  15. 4.3.2 Shandong Huaan Biotechnology Business Overview
  16. 4.3.3 Shandong Huaan Biotechnology Biodegradable Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Shandong Huaan Biotechnology Biodegradable Coronary Stents Product Portfolio
  18. 4.3.5 Shandong Huaan Biotechnology Recent Developments
  19. 4.4 Boston Scientific
  20. 4.4.1 Boston Scientific Company Information
  21. 4.4.2 Boston Scientific Business Overview
  22. 4.4.3 Boston Scientific Biodegradable Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Boston Scientific Biodegradable Coronary Stents Product Portfolio
  24. 4.4.5 Boston Scientific Recent Developments
  25. 4.5 Wego Healthcare
  26. 4.5.1 Wego Healthcare Company Information
  27. 4.5.2 Wego Healthcare Business Overview
  28. 4.5.3 Wego Healthcare Biodegradable Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Wego Healthcare Biodegradable Coronary Stents Product Portfolio
  30. 4.5.5 Wego Healthcare Recent Developments
  31. 4.6 SMT
  32. 4.6.1 SMT Company Information
  33. 4.6.2 SMT Business Overview
  34. 4.6.3 SMT Biodegradable Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 SMT Biodegradable Coronary Stents Product Portfolio
  36. 4.6.5 SMT Recent Developments
  37. 4.7 SINOMED
  38. 4.7.1 SINOMED Company Information
  39. 4.7.2 SINOMED Business Overview
  40. 4.7.3 SINOMED Biodegradable Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 SINOMED Biodegradable Coronary Stents Product Portfolio
  42. 4.7.5 SINOMED Recent Developments
  43. 4.8 REVA Medical (1)
  44. 4.8.1 REVA Medical (1) Company Information
  45. 4.8.2 REVA Medical (1) Business Overview
  46. 4.8.3 REVA Medical (1) Biodegradable Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 REVA Medical (1) Biodegradable Coronary Stents Product Portfolio
  48. 4.8.5 REVA Medical (1) Recent Developments
  49. 4.9 Q3 Medical
  50. 4.9.1 Q3 Medical Company Information
  51. 4.9.2 Q3 Medical Business Overview
  52. 4.9.3 Q3 Medical Biodegradable Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Q3 Medical Biodegradable Coronary Stents Product Portfolio
  54. 4.9.5 Q3 Medical Recent Developments
  55. 4.10 Lepu Medical
  56. 4.10.1 Lepu Medical Company Information
  57. 4.10.2 Lepu Medical Business Overview
  58. 4.10.3 Lepu Medical Biodegradable Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Lepu Medical Biodegradable Coronary Stents Product Portfolio
  60. 4.10.5 Lepu Medical Recent Developments
  61. 4.11 Kyoto Medical
  62. 4.11.1 Kyoto Medical Company Information
  63. 4.11.2 Kyoto Medical Business Overview
  64. 4.11.3 Kyoto Medical Biodegradable Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Kyoto Medical Biodegradable Coronary Stents Product Portfolio
  66. 4.11.5 Kyoto Medical Recent Developments
  67. 4.12 Elixir Medical
  68. 4.12.1 Elixir Medical Company Information
  69. 4.12.2 Elixir Medical Business Overview
  70. 4.12.3 Elixir Medical Biodegradable Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Elixir Medical Biodegradable Coronary Stents Product Portfolio
  72. 4.12.5 Elixir Medical Recent Developments
  73. 4.13 Cardionovum
  74. 4.13.1 Cardionovum Company Information
  75. 4.13.2 Cardionovum Business Overview
  76. 4.13.3 Cardionovum Biodegradable Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Cardionovum Biodegradable Coronary Stents Product Portfolio
  78. 4.13.5 Cardionovum Recent Developments
  79. 4.14 Biotronik
  80. 4.14.1 Biotronik Company Information
  81. 4.14.2 Biotronik Business Overview
  82. 4.14.3 Biotronik Biodegradable Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Biotronik Biodegradable Coronary Stents Product Portfolio
  84. 4.14.5 Biotronik Recent Developments
  85. 4.15 Arterius
  86. 4.15.1 Arterius Company Information
  87. 4.15.2 Arterius Business Overview
  88. 4.15.3 Arterius Biodegradable Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Arterius Biodegradable Coronary Stents Product Portfolio
  90. 4.15.5 Arterius Recent Developments
  91. 4.16 AMG International
  92. 4.16.1 AMG International Company Information
  93. 4.16.2 AMG International Business Overview
  94. 4.16.3 AMG International Biodegradable Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 AMG International Biodegradable Coronary Stents Product Portfolio
  96. 4.16.5 AMG International Recent Developments
  97. 4.17 Amaranth Medical
  98. 4.17.1 Amaranth Medical Company Information
  99. 4.17.2 Amaranth Medical Business Overview
  100. 4.17.3 Amaranth Medical Biodegradable Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Amaranth Medical Biodegradable Coronary Stents Product Portfolio
  102. 4.17.5 Amaranth Medical Recent Developments
  103. 4.18 3M
  104. 4.18.1 3M Company Information
  105. 4.18.2 3M Business Overview
  106. 4.18.3 3M Biodegradable Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 3M Biodegradable Coronary Stents Product Portfolio
  108. 4.18.5 3M Recent Developments
5 Global Biodegradable Coronary Stents Market Scenario by Region
  1. 5.1 Global Biodegradable Coronary Stents Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Biodegradable Coronary Stents Sales by Region: 2021-2032
  3. 5.2.1 Global Biodegradable Coronary Stents Sales by Region: 2021-2026
  4. 5.2.2 Global Biodegradable Coronary Stents Sales by Region: 2027-2032
  5. 5.3 Global Biodegradable Coronary Stents Revenue by Region: 2021-2032
  6. 5.3.1 Global Biodegradable Coronary Stents Revenue by Region: 2021-2026
  7. 5.3.2 Global Biodegradable Coronary Stents Revenue by Region: 2027-2032
  8. 5.4 North America Biodegradable Coronary Stents Market Facts & Figures by Country
  9. 5.4.1 North America Biodegradable Coronary Stents Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Biodegradable Coronary Stents Sales by Country (2021-2032)
  11. 5.4.3 North America Biodegradable Coronary Stents Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Biodegradable Coronary Stents Market Facts & Figures by Country
  16. 5.5.1 Europe Biodegradable Coronary Stents Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Biodegradable Coronary Stents Sales by Country (2021-2032)
  18. 5.5.3 Europe Biodegradable Coronary Stents Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Biodegradable Coronary Stents Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Biodegradable Coronary Stents Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Biodegradable Coronary Stents Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Biodegradable Coronary Stents Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Biodegradable Coronary Stents Market Facts & Figures by Country
  41. 5.7.1 South America Biodegradable Coronary Stents Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Biodegradable Coronary Stents Sales by Country (2021-2032)
  43. 5.7.3 South America Biodegradable Coronary Stents Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Biodegradable Coronary Stents Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Biodegradable Coronary Stents Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Biodegradable Coronary Stents Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Biodegradable Coronary Stents Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Biodegradable Coronary Stents Sales by Type (2021-2032)
  2. 6.1.1 Global Biodegradable Coronary Stents Sales by Type (2021-2032) & (Units)
  3. 6.1.2 Global Biodegradable Coronary Stents Sales Market Share by Type (2021-2032)
  4. 6.2 Global Biodegradable Coronary Stents Revenue by Type (2021-2032)
  5. 6.2.1 Global Biodegradable Coronary Stents Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Biodegradable Coronary Stents Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Biodegradable Coronary Stents Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Biodegradable Coronary Stents Sales by Application (2021-2032)
  2. 7.1.1 Global Biodegradable Coronary Stents Sales by Application (2021-2032) & (Units)
  3. 7.1.2 Global Biodegradable Coronary Stents Sales Market Share by Application (2021-2032)
  4. 7.2 Global Biodegradable Coronary Stents Revenue by Application (2021-2032)
  5. 7.2.1 Global Biodegradable Coronary Stents Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Biodegradable Coronary Stents Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Biodegradable Coronary Stents Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Biodegradable Coronary Stents Value Chain Analysis
  2. 8.1.1 Biodegradable Coronary Stents Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Biodegradable Coronary Stents Production Mode & Process
  5. 8.2 Biodegradable Coronary Stents Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Biodegradable Coronary Stents Distributors
  8. 8.2.3 Biodegradable Coronary Stents Customers
9 Global Biodegradable Coronary Stents Analyzing Market Dynamics
  1. 9.1 Biodegradable Coronary Stents Industry Trends
  2. 9.2 Biodegradable Coronary Stents Industry Drivers
  3. 9.3 Biodegradable Coronary Stents Industry Opportunities and Challenges
  4. 9.4 Biodegradable Coronary Stents Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst